Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction
Journal of Applied Clinical Medical Physics · 2026-06 · 27 (6)
DOI: 10.1002/acm2.70620 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 07.06.2026. Verfasst von Kotaro Iijima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Phantoms, Imaging, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, the National Cancer Center Research and Development Fund, Japan mHDR Research Fund.
Abstract (Originalsprache)
Background
High‐dose‐rate brachytherapy (HDR‐BT) is a critical modality in the treatment of cervical cancer, requiring accurate and efficient treatment planning. Unlike external beam radiation therapy, HDR‐BT demands specialized skills and training. However, accessible and standardized educational tools—particularly virtual phantoms—remain limited.
Purpose
This study aimed to develop a virtual phantom tailored for HDR‐BT treatment planning in cervical cancer management. The objective was to support planner training, reduce interobserver error, and provide a scalable platform for quality assurance and educational use.
Methods
Four virtual phantoms (VP1–VP4) were generated using computed tomography images of physical models equipped with different applicators (Fletcher, Geneva, VCMC, and Venezia). Dose constraints were initially established through a single‐institutional planning study (SIPS) and validated via a multi‐institutional planning study involving seven institutions. Dose–volume parameters (DVPs) were analyzed to assess compliance with the constraints and to quantify inter‐planner error (IPE) and inter‐institutional error (IIE). The coefficient of variation (CV) and F‐tests were employed to evaluate variability.
Results
Initial compliance with SIPS‐defined dose constraints ranged from 35.4% to 70.8%. As compliance was low across all phantoms, we adjusted the spatial relationships between the target volume and organs at risk. The compliance then improved to 83.3%‐100.0%. IIE was greater than IPE, with several DVPs exhibiting CVs above 20%. The hyper‐dose sleeve (V200%) demonstrated the highest variability, with CVs exceeding 40% in some cases. These findings emphasize the importance of standardized training tools for reducing interobserver variability.
Conclusions
The developed virtual phantoms offer practical and accessible tools for HDR‐BT treatment planning education. Its digital format enables broad dissemination and adaptability across institutions, supporting both training and clinical use. Ongoing refinement will be necessary to ensure continued relevance in evolving clinical environments and contribution to consistent, high‐quality care in gynecologic brachytherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
- Section of Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
- Department of Radiology, Mie University Hospital, Tsu, Mie, Japan.
- Department of Radiation Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan.
- Division of Radiology, Department of Clinical Technology, Kagoshima University Hospital, Kagoshima-City, Kagoshima, Japan.
- Division of Radiology, Department of Clinical Technology, Tottori University Hospital, Yonago-City, Tottori, Japan.
ORCID-Profile: Kotaro Iijima, Hiroyuki Okamoto, Jun Takatsu
Förderung
- JSPS KAKENHI
- the National Cancer Center Research and Development Fund
- Japan mHDR Research Fund
Zitieren
APA
Iijima, K., Okamoto, H., Ushijima, T., Ueda, Y., Oku, Y., Toyota, M., Ono, Y., Takatsu, J., Fukunaga, J. I., Murakami, N., & Ohno, T. (2026). Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction. Journal of Applied Clinical Medical Physics, 27(6). https://doi.org/10.1002/acm2.70620
Vancouver
Iijima K, Okamoto H, Ushijima T, Ueda Y, Oku Y, Toyota M, et al. Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction. Journal of Applied Clinical Medical Physics. 2026;27(6). doi:10.1002/acm2.70620
BibTeX
@article{Iijima2026,
author = {Iijima, Kotaro and Okamoto, Hiroyuki and Ushijima, Takahiro and Ueda, Yoshihiro and Oku, Yoshifumi and Toyota, Masahiko and Ono, Yasushi and Takatsu, Jun and Fukunaga, Jun-Ichi and Murakami, Naoya and Ohno, Tatsuya},
title = {Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction},
journal = {Journal of Applied Clinical Medical Physics},
year = {2026},
volume = {27},
number = {6},
doi = {10.1002/acm2.70620}
}
EUVIMED